Search

Your search keyword '"Lin, Enmoore"' showing total 144 results

Search Constraints

Start Over You searched for: Author "Lin, Enmoore" Remove constraint Author: "Lin, Enmoore"
144 results on '"Lin, Enmoore"'

Search Results

2. Reticulocyte Binding Protein Homologue 5 is a target of balancing selection in the Plasmodium falciparum population of Papua New Guinea

3. Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial

4. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis

5. Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study

9. Additional file 4 of Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial

10. Additional file 3 of Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial

11. Additional file 1 of Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial

12. Additional file 5 of Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial

13. Additional file 2 of Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial

15. Metagenomic Hi-C of a Healthy Human Fecal Microbiome Transplant Donor

16. Protective Immunity against Severe Malaria in Children Is Associated with a Limited Repertoire of Antibodies to Conserved PfEMP1 Variants

19. A global network for investigating the genomic epidemiology of malaria

20. Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study

22. Protective Immunity Against Severe Malaria is Associated with a Repertoire of Antibodies to Conserved PfEMP1 Variants

23. Protective immunity against severe malaria is associated with antibodies to a conserved repertoire of PfEMP1 variants

24. Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping

25. Safety and outcomes of 177Lu‐DOTATATE for neuroendocrine tumours: experience in New South Wales, Australia.

27. 130 - In Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis, Fusobacterium is Associated with Lack of Remission, while Metabolic Shifts to Starch Degradation and Short Chain Fatty Acid Production are Associated with Remission – Results from the Randomized Controlled Focus Study

28. Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control study

29. Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development

31. Patterns of protective associations differ for antibodies to P. falciparum ‐infected erythrocytes and merozoites in immunity against malaria in children

32. Author response: Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development

34. An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection

35. 600 Multi Donor Intense Faecal Microbiota Transplantation is an Effective Treatment for Resistant Ulcerative Colitis: A Randomised Placebo-Controlled Trial

36. Donor Recruitment for Fecal Microbiota Transplantation

38. Acquisition of Antibodies against Plasmodium falciparum Merozoites and Malaria Immunity in Young Children and the Influence of Age, Force of Infection, and Magnitude of Response

40. Naturally Acquired Immune Responses to P. vivax Merozoite Surface Protein 3α and Merozoite Surface Protein 9 Are Associated with Reduced Risk of P. vivax Malaria in Young Papua New Guinean Children

43. Pharmacokinetics of Lamivudine and Lamivudine-Triphosphate after Administration of 300 Milligrams and 150 Milligrams Once Daily to Healthy Volunteers: Results of the ENCORE 2 Study

44. Features and Prognosis of Severe Malaria Caused by Plasmodium falciparum, Plasmodium vivax and Mixed Plasmodium Species in Papua New Guinean Children

48. Differential Patterns of Infection and Disease with P. falciparum and P. vivax in Young Papua New Guinean Children

Catalog

Books, media, physical & digital resources